AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

PULSE BIOSCIENCES, INC. Director's Dealing 2021

Jan 28, 2021

32093_dirs_2021-01-27_e5772362-76b7-462e-aaeb-001800453d07.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2021-01-20

Reporting Person: Levinson Mitchell E. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-20	Common Stock	X	107	$7.01	Acquired	3321	Indirect
2021-01-20	Common Stock	X	19	$7.01	Acquired	591	Indirect
2021-01-20	Common Stock	X	19	$7.01	Acquired	591	Indirect
2021-01-20	Common Stock	X	19	$7.01	Acquired	591	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-20	Warrant (right to buy)	$7.01	X	107	Disposed	2025-06-15	Common Stock (107)	Indirect
2021-01-20	Warrant (right to buy)	$7.01	X	19	Disposed	2025-06-15	Common Stock (19)	Indirect
2021-01-20	Warrant (right to buy)	$7.01	X	19	Disposed	2025-06-15	Common Stock (19)	Indirect
2021-01-20	Warrant (right to buy)	$7.01	X	19	Disposed	2025-06-15	Common Stock (19)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	26569	Direct